Molecular variants of angiotensinogen (AGT) have been associated with AGT level and hypertension (HT). However, results from reported studies vary considerably between-and within-studied populations. We performed association analysis of AGT gene variants with AGT levels and HT in samples of African descent families, including 595 Nigerians and 901 African Americans. We evaluated association using haplotypes defined by a set of single-nucleotide polymorphisms selected from a previous detailed study of the gene haplotype structure. In the sample of Nigerian families, AGT haplotype H1 was associated with high plasma level. Results were not significant for blood pressure (BP) or HT. For the African-American population, we found significant association between low plasma AGT level and haplotype H7. Furthermore, we found weak associations of H1 with hypertensive status and H7 with low systolic BP. However, no significant association between H1 and high plasma level was found. We conclude that the two distantly related haplotypes, H1 and H7, are associated, but have opposite effects on the phenotypes in two populations of African origin.
Introduction
The renin-angiotensin-aldosterone system (RAA system) contributes to blood pressure (BP) regulation by influencing vascular tone and water-sodium reabsorption. The physiological significance of this pathway has prompted intensive study by genetic epidemiologists to identify genetic variants associated with human hypertension (HT). However, the associations of RAA system genes with HT and BP variation are still poorly characterized. 1 The ability to genetically map and characterize variants associated with HT and BP has been complicated by the fact that both traits are end points of complex physiological processes involving interaction between genes and environment. One way to decrease the genetic heterogeneity and increase the power in genetic studies of human complex diseases is to follow a two-stage approach: first studying an intermediate phenotype and then testing the significant results in a study of the clinically relevant end point. 2 Over the last decade, a series of reports have investigated the association between angiotensinogen (AGT) variants with AGT level and HT. [3] [4] [5] [6] [7] [8] However, the overall results are inconsistent. [9] [10] [11] [12] [13] [14] Most of these studies used a very small limited number of single-nucleotide polymorphisms (SNPs) in the AGT gene (i.e., 1 or 2). The main drawback to this approach is that, if these SNPs are not causal SNPs or are not in strong linkage disequilibrium (LD) with causal SNPs, the power to detect association will be limited. Association studies with more SNP markers representing the overall genetic variation of the AGT gene will potentially increase power. We recently published a study of overall genetic variation of the AGT gene in a Nigerian population, 15 using a small sample of individuals. In the present study, we tested the association of the AGT gene with AGT level, HT and BP, using a selected set of SNPs representing the overall haplotype variation in the AGT gene in two samples of African ancestry collected from a rural area in Nigeria and a metropolitan Chicago area in the US.
We are assuming that these two populations are genetically similar, their difference being a mean proportion of European admixture of 18% 16 in the African Americans. However, they are exposed to extremely different environments (Westernized urban lifestyle compared to traditional rural lifestyle). By studying these two populations, we are gaining insight into the effect that the environment has on the genetic predisposition to AGT plasma level and HT.
Materials and methods

Participant recruitment and measurements
The sampling scheme for this study was provided by the International Collaborative Study on Hypertension in Blacks, as described in detail elsewhere. 17, 18 The sampled populations included 595 Nigerians (184 families) from rural Nigeria and 901 African Americans (324 families) from metropolitan Chicago. AGT serum level was measured with an assay relying on the generation of angiotensin I, as described previously. 19 For the Nigerian population, no participants reported consistent treatment for HT. For the African American, 173 participants reported consistent treatment for HT. HT was defined as systolic blood pressure (SBP) higher than 140 mm Hg or diastolic blood pressure (DBP) higher than 90 mm Hg or under anti-HT treatment at the time an individual's BP was measured. Study protocols were reviewed and approved by the review boards of the participating institutions. Screens with elevated BP in both sites were referred for treatment.
SNP selection and genotyping
In a previous study, 15 a 6.8-kb segment of the AGT gene was sequenced in 57 Nigerian male subjects with high and low AGT plasma levels. Forty-seven non-singleton polymorphisms were identified from which seven major haplotype groups were defined. Ten SNPs were selected for genotyping in this study (Table 1) . These SNPs were chosen to represent the seven haplotype groups in the original 57 Nigerians.
Another SNP, 11 535, was also selected for genotyping based on a report that showed that this SNP divides one of the most interesting haplotype groups (À6G/235M) approximately in half, which could potentially reduce the functional heterogeneity within it. 20 Genotyping of all SNPs was performed at the Medical Research Council's facilities (Cambridge, UK), using standard Taqman fluorescent probes on an ABI 7900HT Sequence Detection System (Applied Biosystems, Foster City, CA, USA). The ABI services were used for the design of the 10 assays applied to the AGT genotyping. Only eight of these assays were successful, two of them failing the ABI design/production stage (positions 4072 and À6) and they were not included in the genotyping.
Statistical analyses
Descriptive statistics were calculated with SAS 8.0 (SAS Institute, Cary, NC, USA). 21 Linear regression analyses were performed using SOLAR 22 to account for the dependency among relatives within families. Heritabilities were calculated using a variance components method implemented in SOLAR.
Hardy-Weinberg equilibrium was tested in the founders with software Merlin. 23 The family-based association test (FBAT) 24, 25 was used for association tests with single SNPs and also haplotypes. This method is a generalization of the traditional transmission/disequilibrium test (TDT). It is robust to population stratification and can be used in a general pedigree. It can be used for both qualitative and quantitative traits. Multiple testing was corrected using a method based on spectral decomposition (SNPSpD). 26 Owing to the existence of LD among SNPs close to each other, a Bonferroni correction could be too conservative. The SNPSpD method incorporates this dependency and will give an effective number of independent markers. Since as many as 19% of individuals in the Maywood sample were being treated for HT, we evaluated the association of the haplotypes and SNPs with hypertensive status instead of BP in this sample. Angiotensinogen on serum levels and BP L Fejerman et al
Results
Summary statistics for both populations are listed in Table 2 . The mean AGT levels were significantly higher in women than in men in both samples (Po0.05). AGT levels were significantly higher in the African Americans than in the Nigerians for both men and women ( Table 2 ). The mean BP was higher in the Nigerians than in the African Americans, which could be caused by lower anti-HT treatment in the Nigerians and different ascertainment strategies in the two samples. We performed simple linear regressions using AGT level, SBP and DBP as dependent variables.
For AGT level we used age, sex and body mass index (BMI) as independent variables. In the Nigerians, sex and BMI were significant predictors (Po0.05) of AGT level. In the US sample, only sex was a significant predictor of AGT level. After adjusting for the significant covariates, the heritability of AGT level was 0.61 in Nigeria and 0.28 in the US. For SBP and DBP, we included sex, age, BMI and AGT level as independent variables. In the Nigerian population, age and BMI were significant predictors of SBP. AGT level was marginally significant (P ¼ 0.07). For DBP, age, BMI and AGT level were all significant predictors. In the AfricanAmerican population, only age, sex and BMI were significant predictors (Po0.01) for both SBP and DBP.
We used generalized TDT methods implemented in FBAT to perform association tests with both single SNPs and haplotypes for AGT level. For the Nigerian population, no significant association was found in the single SNP analysis after controlling for multiple testing with SNPSpD (the corrected a-value ¼ 0.008). The haplotype analysis was conducted using five of the eight SNPs (positions À1074, À532, 384, 1164 and 2186). Two SNPs, À217 and À775, were not included because they are nearly in complete LD with the SNPs at 384 and 2186, respectively. Another SNP at position 11 535 was removed because the division generated in H7 was not informative with respect to AGT plasma level. Haplotypes with frequency higher than 0.01 are listed in Table 3 . We used the same haplotype ID (H1, H2, H3, H4, H6 and H7) as those in our earlier work. 15 A significant association was observed for H1 with AGT level (P ¼ 0.042) ( Table 3 ). The expected mean AGT level of H1 haplotype is higher than the overall average.
For the African Americans, no significant association was found in single SNP association analysis with AGT level. In haplotype analysis, H7 showed a significant association (P ¼ 0.011) with AGT level. The mean AGT level of H7 is lower than the average and can be considered as a protective haplotype. Haplotypes H1 and H2 have expected mean AGT levels that are slightly higher than the overall mean (P ¼ 0.11 and 0.09, respectively; Table 3 ). The analysis of the effect of the different AGT haplotypes on BP or hypertensive status produced negative results. However, in the case of the assessment of the association between AGT haplotypes and BP in the African-American families, association is suggested for haplotype H1 with hypertensive status (P ¼ 0.055) and haplotype H7 with low SBP (P ¼ 0.054).
Discussion
The results from the sample of Nigerian individuals in the present study show that haplotype H1 is associated with high AGT plasma level (Table 3 ). In the African Americans, there is evidence for the association between the H7 haplotype and low AGT plasma level as well as for H1 and HT and H7 and low SBP. Our result supports the hypothesis of association between the À6G/235M haplotype and low AGT plasma level, 27 and shows for the first time that this association is present in a population of African descent.
Although significant associations between the 235T/À6A variants and HT have been reported in European and Asian populations, 28 it was not until recently that an association between a particular AGT haplotype and HT was observed in African Americans. 13, [29] [30] [31] Two recent studies involving African-American samples reported associations between the H1 haplotype (the variants that defined the associated haplotype in both studies are the ones that define our H1) and HT. 32, 33 Our study also found an association between H1 and HT in the sample of African Americans. The fact that two other recent studies observed, this association is very encouraging given the long history of inconsistent results between studies for the AGT gene.
The H1 haplotype, however, is not associated with AGT plasma level in the African Americans. As the two populations are exposed to very different environments (e.g., in terms of salt intake, level of exercise, stress and diet), it is possible that the power of the study is affected in the African Americans by the confounding effect of environmental risk factors.
It is interesting to note that haplotype H1 is similar to the chimpanzee sequence in the promoter region, which has been found to be involved in changes in the expression levels of the protein. [34] [35] [36] Studies conducted on chimpanzees showed that when exposed to high salt diets their BP levels increase, which is consistent with adaptation to a low sodium environment. 37 This evidence supports the hypothesis that modern humans inherited from their ancestors a gene that was adaptive in an environment low in sodium.
The presence of a protective haplotype (H7) for AGT level and HT, the characteristics of the haplotype (many SNPs along the gene in total LD, and low level of diversity within the haplotype) and the frequency differences between African (10% for the 235M variant) and European populations (54% for the 235M variant) have been used as evidence, suggesting a selective sweep originated after modern humans left Africa and moved to more temperate climates. 27 However, when tests of selection are applied to the entire gene, no evidence of a selective sweep or any other form of selection is present. Furthermore, other sites, like the À217, À20 and À18 have been shown to affect basal transcription rates 34, 36 and therefore the À6 position is just one among many that could influence the levels of gene expression.
The frequency of the H7 haplotype is higher in African Americans (0.25) than in the Nigerians (0.13), probably owing to European admixture. The frequency difference could be affecting the power of the analysis in the Nigerians.
The observed frequencies and patterns of haplotype variation are compatible with a founder effect. The intermediate frequency of the 235M variant (20-30%) in Asian populations also supports this hypothesis, as it is reasonable to speculate that the European and Asian populations are different sampling outcomes of the same source populations in Eurasia. It is likely that the mutation or mutations linked to the H1 haplotype, and therefore associated with high AGT plasma levels, were high in frequency in the ancestral humans from whom modern humans evolved. It can be speculated that low-frequency haplotypes (like H7), with lowering effects on AGT level, have a high frequency in European populations owing to a founder effect during the peopling of that region.
